Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Study of the Efficacy of Biologics vs Usual Treatment on OCS Reduction for Severe Asthma Patients Using Health Insurance Claim Database

NCT05136547 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05136547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05136547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Study of the Efficacy of Biologics vs Usual Treatment on OCS Reduction for Severe Asthma Patients Using Health Insurance Claim Database
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
January 6, 2022
Completion date
May 16, 2022
Enrollment
2,927 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma